Press release
November 24, 2025
Press releases
Browse our latest press releases below, or visit our investor site directly for a complete list of all recent and archived press releases.
Press release
November 24, 2025
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
Press release
November 6, 2025
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
Press release
November 6, 2025
Lantheus Announces Leadership Transition Plan
Press release
October 30, 2025
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Press release
October 28, 2025
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
Press release
October 28, 2025
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
Press release
October 23, 2025
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
Press release
October 23, 2025
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
For access to press releases before 2022 and full-text search capabilities, please visit our investor site.